C9orf72 and mild neurocognitive disorder: Disease duration in FTLD has been reported to be approximately 7 years in PGRN and MAPT [106] and 5 years in C9orf72. This can be explained by the high frequency of MND/ALS reported among FTLD-C9orf72 carriers (> 40%) [52].